Anaphylactic shock caused by immunoglobulin E sensitization after retreatment with the chimeric anti–interleukin-2 receptor monoclonal antibody basiliximab
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Transplantation
Reference15 articles.
1. Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients: CHIB 201 International Study Group;Nashan;Lancet,1997
2. Interleukin-2-receptor blockade with daclizumab to prevent acute rejection in renal transplantation: Daclizumab Triple Therapy Study Group;Vincenti;N Engl J Med,1998
3. Reduction of the occurrence of acute cellular rejection among renal allograft recipients treated with basiliximab, a chimeric anti-interleukin-2-receptor monoclonal antibody: United States Simulect Renal Study Group;Kahan;Transplantation,1999
4. Reduction of acute renal allograft rejection by daclizumab: Daclizumab Double Therapy Study Group;Nashan;Transplantation,1999
5. A randomized, double-blind trial of basiliximab immunoprophylaxis plus triple therapy in kidney transplant recipients;Ponticelli;Transplantation,2001
Cited by 72 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Hantavirus: an overview and advancements in therapeutic approaches for infection;Frontiers in Microbiology;2023-10-12
2. Plants with Immunomodulatory Potential Described in Ayurveda;Bioprospecting of Tropical Medicinal Plants;2023
3. Solanaceous Plants for Immunomodulation;Plants and Phytomolecules for Immunomodulation;2022
4. Fatal anaphylaxis due to alpha-gal syndrome after initial cetuximab administration: The first forensic case report;Legal Medicine;2021-07
5. Immunogenicity of CAR T cells in cancer therapy;Nature Reviews Clinical Oncology;2021-02-25
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3